Epitalon
Tetrapeptide telomerase activator derived from pineal gland extract epithalamin
- Class
- Pineal tetrapeptide
- Half-life
- ~30 min
- Route
- Subcutaneous (SubQ)
- Cadence
- Cycled (on/off)
- Evidence
- Mixed / early human
Overview
Epitalon is a four-amino-acid peptide (Ala-Glu-Asp-Gly) developed by Russian gerontologist Vladimir Khavinson in the 1980s as a synthetic version of epithalamin, a bovine pineal gland extract. The central claim — and the reason it's become a fixture in longevity circles — is that it activates telomerase in human cells, potentially lengthening telomeres and slowing the cellular aging clock. It also appears to nudge the pineal gland to restore youthful melatonin rhythms in older people, which matters for sleep, circadian health, and possibly a lot more.
The evidence base is real but concentrated. Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology has published dozens of studies over four decades — in vitro work showing telomerase activation in human fibroblasts, animal lifespan extensions in rats and mice, and small human observational studies reporting increased telomere length and normalized melatonin patterns in elderly patients. The 2003 Bulletin of Experimental Biology and Medicine paper showing that epitalon extended the Hayflick limit in cultured cells by ~42% is the one everyone cites.
The problem: almost all of this evidence comes from one lab in Russia. Independent replication in Western journals is thin — a 2025 Biogerontology paper from Brunel University finally confirmed the telomerase effect in human cell lines, but large-scale RCTs don't exist. No approval anywhere; the peptide on the research market is unregulated. If you're looking at epitalon, you're making a bet on a scientifically plausible mechanism backed by decades of work from a single, prolific research group — not the kind of multi-center, FDA-vetted evidence base you'd get with a mainstream drug.
Safety considerations
A few of the safety signals worth knowing — the full list, with dosing context and what to monitor, is inside AIx Core.
- Not approved by FDA, EMA, or any major regulator. Sold as a research peptide with no regulatory oversight on purity, peptide content, or sterility.
- Korkushko et al. 2004 and other observational studies from Khavinson's institute report minimal side effects (primarily transient injection site reactions) in elderly cohorts, but none were randomized or blinded and adverse-event tracking was not systematically reported.
- Theoretical concern: activating telomerase in the wrong cells could support cancer growth — telomerase reactivation is one of the hallmarks of malignancy. Animal studies in Khavinson's group showed reduced tumor incidence, not increased, but this paradox hasn't been mechanistically resolved and independent confirmation is lacking.
+ 3 more safety notes inside AIx Core →
Commonly monitored
Markers and signals people track when researching Epitalon.
- Subjective sleep quality and sleep latency
- Telomere length (specialized lab test — not part of routine bloodwork)
- Fasting glucose and insulin (pineal peptides can modulate metabolic rhythms)
- Melatonin rhythm if accessible (salivary or serum)
- Markers of circadian health: cortisol awakening response, subjective energy patterns
Frequently asked questions
What is Epitalon?
Tetrapeptide telomerase activator derived from pineal gland extract epithalamin. Epitalon is a four-amino-acid peptide (Ala-Glu-Asp-Gly) developed by Russian gerontologist Vladimir Khavinson in the 1980s as a synthetic version of epithalamin, a bovine pineal gland extract. The central claim — and the reason it's become a fixture in longevity circles — is that it activates telomerase in human cells, potentially lengthening telomeres and slowing the cellular aging clock. It also appears to nudge the pineal gland to restore youthful melatonin rhythms in older people, which matters for sleep, circadian health, and possibly a lot more.
How is Epitalon administered?
Subcutaneous (SubQ), typically cycled (on/off).
What is the half-life of Epitalon?
~30 min — Short plasma half-life, but effects on gene expression and telomerase activity persist well beyond peptide clearance.
Is Epitalon approved for human use?
Epitalon is investigational — not approved by the FDA, EMA, or MHRA for human use at the time of writing.
What does the evidence show for Epitalon?
Evidence tier: Mixed / early human. Khavinson et al. 2003 (Bull Exp Biol Med) showed epitalon activated telomerase and extended fibroblast replicative lifespan in vitro, with treated cells reaching ~44 passages compared to 34 in controls — approximately 10 additional cell doublings beyond the normal Hayflick limit.
What is commonly monitored when researching Epitalon?
Commonly tracked markers + signals: Subjective sleep quality and sleep latency, Telomere length (specialized lab test — not part of routine bloodwork), Fasting glucose and insulin (pineal peptides can modulate metabolic rhythms), Melatonin rhythm if accessible (salivary or serum), Markers of circadian health: cortisol awakening response, subjective energy patterns.
Related compounds
Open this in AIx Core for the full picture
Mechanism breakdown, receptor pathway diagram, full safety list, monitored items, source citations, and one-tap add-to-protocol. Free with any account.